BACKGROUND: Many factors, including severity of illness, neutropenia,
intravenous catheter management, and drug therapy may affect the outco
me of candidemia in cancer patients. METHODS: The records of all patie
nts at M. D. Anderson Cancer Center who developed one or more positive
blood cultures for Candida spp between January 1, 1988, and December
31, 1992, were retrospectively reviewed. Four hundred ninety one episo
des of candidemia were identified, for which 476 had complete medical
records, which were reviewed in detail. RESULTS: By 3-month follow-up,
52% of the patients had died. Neutropenia, higher APACHE III score, a
nd visceral dissemination were associated with poor prognosis. Cure ra
tes, adjusted for severity of illness, were similar for fluconazole an
d amphotericin B treatment. Exchange of central venous catheters was a
ssociated with a modest improvement in prognosis. CONCLUSION: Several
factors that influence the outcome of candidemia in cancer patients ha
ve been identified. These factors may be relevant for the clinical man
agement of cancer patients with candidemia, and for the design of ther
apeutic trials.